Aquestive Therapeutics, Inc.AQ.STNASDAQ
Loading
P/E Ratio: Premium ValuationElevated
Percentile Rank100
3Y CAGR+24.6%
5Y CAGR+16.5%
Year-over-Year Change
Price-to-earnings ratio
3Y CAGR
+24.6%/yr
vs -6.5%/yr prior
5Y CAGR
+16.5%/yr
Recent acceleration
Acceleration
+31.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
3 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 26.72 | +38.8% |
| 2024 | 19.26 | +34.7% |
| 2023 | 14.30 | +3.5% |
| 2022 | 13.81 | -23.6% |
| 2021 | 18.08 | +45.5% |
| 2020 | 12.43 | -22.6% |
| 2019 | 16.06 | -11.2% |
| 2018 | 18.09 | -8.4% |
| 2017 | 19.75 | +33.8% |
| 2016 | 14.76 | - |